Skip to main content

Find Clinical Trials

Home
Conditions
Influenza

Clinical trial condition

Influenza

Explore clinical trials studying Influenza. Study availability and eligibility vary by location and protocol.

1,207 public trials 47 recruiting studies

Refine in advanced search Browse all conditions

Influenza trial results

Completed

Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years

NCT01035749

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Tartu, Estonia

GSK Investigational Site Cífer, Slovakia

GSK Investigational Site Dolný Kubín, Slovakia

GSK Investigational Site Dunajská Streda, Slovakia

View Trial Details

Completed

Evaluation of Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Years and Older

NCT00760617

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Güglingen, Baden-Wurttemberg, Germany

GSK Investigational Site Mannheim, Baden-Wurttemberg, Germany

GSK Investigational Site Rudersberg, Baden-Wurttemberg, Germany

GSK Investigational Site Weinheim, Baden-Wurttemberg, Germany

View all 25 locations

View Trial Details

Completed

Systems Biology of Flu Vaccine in Healthy Adults With and Without the Use of Antibiotics

NCT02154061

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Emory Vaccine Center Atlanta, Georgia, United States

View Trial Details

Completed

Safety Study of Four Candidate Influenza Vaccines to Prevent Influenza Disease in the Elderly Population

NCT00318149

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Ghent, Belgium

View Trial Details

Completed

Study to Evaluate Immunological Equivalence Between Two Investigational Influenza Vaccines in Adults (H1N1)

NCT00979407

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Caen, France

GSK Investigational Site Paris, France

GSK Investigational Site Paris, France

GSK Investigational Site Poitiers, France

View Trial Details

Completed

Influenza Vaccine Trial in HIV Uninfected Pregnant Women

NCT01306669

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: RMPRU, Chris Hani Baragwanath Hospital Johannesburg, Gauteng, South Africa

View Trial Details

Completed

Immunogenicity of GSK Biologicals' Pandemic Influenza Vaccine (GSK1562902A) at Different Boosting Vaccination Schedules

NCT00652743

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Hong Kong

GSK Investigational Site Singapore

GSK Investigational Site Singapore

GSK Investigational Site Taipei, Taiwan

View Trial Details

Completed

A Study to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine in Children

NCT01218308

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Dhaka, Bangladesh

GSK Investigational Site Santo Domingo, Dominican Republic

GSK Investigational Site Tegucigalpa, Honduras

GSK Investigational Site Beirut, Lebanon

View Trial Details

Completed

Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults

NCT00985673

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Stockbridge, Georgia, United States

GSK Investigational Site Raleigh, North Carolina, United States

GSK Investigational Site Austin, Texas, United States

GSK Investigational Site Fort Worth, Texas, United States

View Trial Details

Completed

Evaluation of the Safety and Immunogenicity of the Influenza Vaccine GSK2186877A in the Elderly

NCT00772889

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Clearwater, Florida, United States

GSK Investigational Site Coral Gables, Florida, United States

GSK Investigational Site Milford, Massachusetts, United States

GSK Investigational Site Chaska, Minnesota, United States

View all 29 locations

View Trial Details